This Viewpoint discusses the health benefits of glucagon-like peptide-1 receptor agonists (GLP-1 RAs); summarizes the clinical, policy, and equity implications of GLP-1 RA discontinuation; and calls for the identification and implementation of strategies to improve long-term adherence to GLP-1 RA therapy.

中文翻译：

---

停用胰高血糖素样肽-1 受体激动剂


本观点讨论了胰高血糖素样肽-1 受体激动剂 （GLP-1 RAs） 的健康益处;总结了停用 GLP-1 RA 的临床、政策和公平影响;并呼吁确定和实施策略以提高对 GLP-1 RA 治疗的长期依从性。